Literature DB >> 15930202

Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance.

Amy Fleischman1, Catherine Brue, Tina Young Poussaint, Mark Kieran, Scott L Pomeroy, Liliana Goumnerova, R Michael Scott, Laurie E Cohen.   

Abstract

Diencephalic syndrome is a rare but potentially lethal cause of failure to thrive in infants and young children. The diencephalic syndrome includes clinical characteristics of severe emaciation, normal linear growth, and normal or precocious intellectual development in association with central nervous system tumors. Our group initially described a series of 9 patients with diencephalic syndrome and found a reduced prevalence of emesis, hyperalertness, or hyperactivity compared with previous reports. Also, the tumors were found to be larger, occur at a younger age, and behave more aggressively than similarly located tumors without diencephalic syndrome. We have been able to extend our follow-up of the original patients, as well as describe 2 additional cases. Because the mechanism of the growth and endocrinologic findings in diencephalic syndrome has not been explained, we report on these patients in light of current research on hypothalamic factors that affect growth and weight. This study emphasizes diencephalic syndrome as a model for additional study of growth hormone resistance and metabolic regulation of adiposity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930202     DOI: 10.1542/peds.2004-2237

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Case 3: An eight-month-old boy with failure to thrive.

Authors:  Andrea Human; Kamal Eltobgy; Carolyn E Beck
Journal:  Paediatr Child Health       Date:  2014-11       Impact factor: 2.253

2.  Lymphomatosis cerebri presenting with orthostatic hypotension, anorexia, and paraparesis.

Authors:  Anjeni Keswani; Eileen Bigio; Sean Grimm
Journal:  J Neurooncol       Date:  2012-07-18       Impact factor: 4.130

3.  Anorexia: an early sign of fourth ventricle astrocytoma in children.

Authors:  Henri-Arthur Leroy; Marc Baroncini; Isabelle Delestret; Vincent Florent; Matthieu Vinchon
Journal:  Childs Nerv Syst       Date:  2014-08-21       Impact factor: 1.475

4.  Diencephalic syndrome: an anaesthetic challenge.

Authors:  Bhim Raju Roncall; Snigdha Bellapukonda; Chitta Ranjan Mohanty
Journal:  BMJ Case Rep       Date:  2019-07-08

5.  Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome.

Authors:  Iacopo Sardi; Cecilia Bresci; Elisabetta Schiavello; Veronica Biassoni; Valentina Fratoni; Stefania Cardellicchio; Lorenzo Genitori; Maurizio Aricò; Maura Massimino
Journal:  J Neurooncol       Date:  2012-06-21       Impact factor: 4.130

6.  Diencephalic syndrome: a rare cause of failure to thrive.

Authors:  Mustafa Tosur; Anca Tomsa; David L Paul
Journal:  BMJ Case Rep       Date:  2017-07-06

7.  Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach.

Authors:  John-Paul Kilday; Ute Bartels; Annie Huang; Mary Barron; Mary Shago; Matthew Mistry; Nataliya Zhukova; Normand Laperriere; Peter Dirks; Cynthia Hawkins; Eric Bouffet; Uri Tabori
Journal:  J Neurooncol       Date:  2013-11-12       Impact factor: 4.130

8.  Rare infundibular tumors: clinical presentation, imaging findings, and the role of endoscopic endonasal surgery in their management.

Authors:  Maria Koutourousiou; Paul A Gardner; Julia K Kofler; Juan C Fernandez-Miranda; Carl H Snyderman; L Dade Lunsford
Journal:  J Neurol Surg B Skull Base       Date:  2012-12-31

9.  A Novel Syndrome of Generalized Lipodystrophy Associated With Pilocytic Astrocytoma.

Authors:  Nivedita Patni; Crésio Alves; Julia von Schnurbein; Martin Wabitsch; Grace Tannin; Dinesh Rakheja; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2015-08-07       Impact factor: 5.958

10.  Hypothalamic Pilomyxoid Astrocytoma in a Child with Lipodystrophy.

Authors:  J C Benson; J Trejo-Lopez; S E Bach; J Schwartz; T J Kaufmann; L Eckel; J Guerin
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-06       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.